Blood Test
Gene-based blood test may predict melanoma recurrence
Monitoring blood levels of circulating tumor DNA in patients with stage 3 melanoma may accurately predict skin cancer recurrence, according to results from a phase 3 study published in The Lancet Oncology.
Survey: Americans embracing proactivity with Alzheimer’s detection, treatment and care
Most Americans want to be proactive when faced with a diagnosis of Alzheimer’s disease, wishing to know as soon as possible and asking for simple, rapid and accurate testing, according to recent survey results.
Dana-Farber researchers receive $5M grant for childhood cancer research
Dana-Farber Cancer Institute and Boston Children’s Cancer and Blood Disorders Center have received a 4-year, $5 million Alex’s Lemonade Stand Foundation Crazy 8 Award for childhood cancer research, according to a press release.
Novel blood test could be first step to early detection of pancreatic cancer
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a retrospective study.
Second-trimester blood test predicts premature birth for average-risk women
Compared with usual care, a mid-trimester blood test designed to predict preterm birth for average-risk women markedly reduced neonatal morbidity when paired with a three-step treatment bundle, researchers reported at The Pregnancy Meeting.
Blood test may improve decision-making in Alzheimer’s disease
A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and subsequently for assisting clinicians in formulating a treatment plan for patients, according to new research.
Blood test uses cyclic adenosine monophosphate to diagnose asthma
Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its severity, according to a study published in The Journal of Clinical Investigation.
Blood-based test could increase adherence to colorectal cancer screening
An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.
Biomarkers may enable blood test for early Alzheimer’s disease, explain sex disparity
Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its derivative free carnitine, which may enable blood-based biomarker detection of the disease, according to a study.
Top in women’s health: Study on breast cancer screening; blood test for preeclampsia risk
WISDOM, a research study comparing annual mammography with a personalized approach to screening based on individual risk factors, is currently underway and enrolling women in the U.S. aged 30 to 74 years without a history of breast cancer.